S2 Episode 3: Does Your Patient Have IgA Nephropathy?
Medscape,
This transcript has been edited for clarity. Matthew A. Sparks, MD: Hi. I'm Dr Matthew Sparks.
This transcript has been edited for clarity. Matthew A. Sparks, MD: Hi. I'm Dr Matthew Sparks.
/felipecaparros, stock.adobe.com Peking Eine niedrig dosierte Behandlung mit Methylprednisolon kann bei Patienten mit IgA…
The US Food and Drug Administration (FDA) announced accelerated approval for budesonide delayed release capsules (Tarpeyo) to…
Daily treatment of patients with IgA nephropathy with an oral glucocorticoid, methylprednisolone, led to significant reductions…